Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial Monday, 28 September 2026 06:00 PM Company Update WINNIPEG, MB / ACCESS Newswire / September 28, 2026 / Medicure Inc. (" Medicure" or the " Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today ...